| Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target S Lechner, MIP Malgapo, C Grätz, RR Steimbach, A Baron, P Rüther, ... Nature chemical biology 18 (8), 812-820, 2022 | 46 | 2022 |
| Decrypting drug actions and protein modifications by dose-and time-resolved proteomics J Zecha, FP Bayer, S Wiechmann, J Woortman, N Berner, J Müller, ... Science 380 (6640), 93-101, 2023 | 24 | 2023 |
| Development of selective inhibitors of phosphatidylinositol 3-kinase C2α WT Lo, H Belabed, M Kücükdisli, J Metag, Y Roske, P Prokofeva, ... Nature chemical biology 19 (1), 18-27, 2023 | 12 | 2023 |
| Merits of Diazirine Photo-Immobilization for Target Profiling of Natural Products and Cofactors P Prokofeva, S Höfer, M Hornisch, M Abele, B Kuster, G Médard ACS Chemical Biology 17 (11), 3100-3109, 2022 | 3 | 2022 |
| Target deconvolution of HDAC pharmacopoeia highlights MBLAC2 as common off-target S Lechner, M Malgapo, C Grätz, A Baron, PL Rüther, S Nadal, C Stumpf, ... | 1 | 2021 |
| Structural Basis for Highly Selective Class II Alpha Phosphoinositide-3-Kinase Inhibition M Kücükdisli, H Bel-Abed, D Cirillo, WT Lo, NL Efrém, A Horatscheck, ... Journal of Medicinal Chemistry 66 (20), 14278-14302, 2023 | | 2023 |
| Targeting cancer with small molecule pan-KRAS degraders J Popow, W Farnaby, A Gollner, C Kofink, G Fischer, M Wurm, D Zollman, ... bioRxiv, 2023.10. 24.563163, 2023 | | 2023 |
| Pushing the boundaries of affinity-based target deconvolution: Promiscuous immobilization of nature-made molecules and proteome-wide medicinal chemistry P Prokofeva Technische Universität München, 2023 | | 2023 |
